Cigna Group (CI) Competitors $319.48 -0.92 (-0.29%) Closing price 07/3/2025 03:54 PM EasternExtended Trading$316.10 -3.38 (-1.06%) As of 07/3/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CI vs. CNC, ELV, HCA, HUM, UNH, MOH, SEM, JYNT, AEMD, and ABBVShould you be buying Cigna Group stock or one of its competitors? The main competitors of Cigna Group include Centene (CNC), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), UnitedHealth Group (UNH), Molina Healthcare (MOH), Select Medical (SEM), Joint (JYNT), Aethlon Medical (AEMD), and AbbVie (ABBV). These companies are all part of the "medical" sector. Cigna Group vs. Its Competitors Centene Elevance Health HCA Healthcare Humana UnitedHealth Group Molina Healthcare Select Medical Joint Aethlon Medical AbbVie Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Does the media prefer CI or CNC? In the previous week, Centene had 68 more articles in the media than Cigna Group. MarketBeat recorded 90 mentions for Centene and 22 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.23 beat Centene's score of -0.01 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 18 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 17 Very Positive mention(s) 11 Positive mention(s) 26 Neutral mention(s) 19 Negative mention(s) 8 Very Negative mention(s) Neutral Which has better earnings and valuation, CI or CNC? Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCigna Group$254.47B0.34$3.43B$18.0617.69Centene$163.07B0.10$3.31B$6.714.96 Do insiders and institutionals hold more shares of CI or CNC? 87.0% of Cigna Group shares are held by institutional investors. Comparatively, 93.6% of Centene shares are held by institutional investors. 0.7% of Cigna Group shares are held by insiders. Comparatively, 0.4% of Centene shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is CI or CNC more profitable? Centene has a net margin of 2.04% compared to Cigna Group's net margin of 1.97%. Cigna Group's return on equity of 18.63% beat Centene's return on equity.Company Net Margins Return on Equity Return on Assets Cigna Group1.97% 18.63% 4.97% Centene 2.04%14.56%4.75% Which has more risk and volatility, CI or CNC? Cigna Group has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Comparatively, Centene has a beta of 0.44, suggesting that its share price is 56% less volatile than the S&P 500. Do analysts prefer CI or CNC? Cigna Group presently has a consensus price target of $380.39, suggesting a potential upside of 19.07%. Centene has a consensus price target of $68.87, suggesting a potential upside of 106.96%. Given Centene's higher probable upside, analysts clearly believe Centene is more favorable than Cigna Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cigna Group 0 Sell rating(s) 2 Hold rating(s) 16 Buy rating(s) 2 Strong Buy rating(s) 3.00Centene 0 Sell rating(s) 10 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.41 SummaryCigna Group beats Centene on 12 of the 16 factors compared between the two stocks. Get Cigna Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CI vs. The Competition Export to ExcelMetricCigna GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$85.42B$42.60B$5.55B$20.71BDividend Yield1.89%111.92%5.22%3.71%P/E Ratio17.699.4327.6628.08Price / Sales0.341.40418.7238.37Price / Cash8.469.2236.8922.53Price / Book2.152.718.034.58Net Income$3.43B$2.64B$3.18B$985.54M7 Day Performance-2.21%-6.34%2.93%2.79%1 Month Performance2.50%-11.83%1.72%4.37%1 Year Performance0.11%-30.45%34.39%15.08% Cigna Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CICigna Group4.9732 of 5 stars$319.48-0.3%$380.39+19.1%+0.1%$85.42B$254.47B17.6973,500Positive NewsCNCCentene4.9747 of 5 stars$54.22+0.4%$77.71+43.3%-49.9%$26.98B$163.07B8.0874,300Trending NewsAnalyst ForecastOptions VolumeAnalyst RevisionELVElevance Health4.9724 of 5 stars$389.42+2.1%$498.87+28.1%-34.2%$87.98B$183.12B15.19102,300HCAHCA Healthcare4.8237 of 5 stars$383.21+1.0%$395.71+3.3%+16.4%$92.19B$70.60B17.04294,000Positive NewsAnalyst UpgradeHUMHumana4.6442 of 5 stars$244.30+1.0%$280.76+14.9%-35.3%$29.49B$120.26B17.2867,100Trending NewsAnalyst RevisionUNHUnitedHealth Group4.9977 of 5 stars$311.89+0.9%$415.57+33.2%-36.7%$282.93B$400.28B13.06400,000Positive NewsOptions VolumeMOHMolina Healthcare4.9885 of 5 stars$297.09+0.0%$364.21+22.6%-18.3%$16.10B$40.65B14.3518,000News CoverageSEMSelect Medical5 of 5 stars$15.19-0.5%$26.00+71.2%-57.7%$1.95B$5.19B11.3444,100Positive NewsJYNTJoint3.0273 of 5 stars$11.56+1.2%$15.50+34.1%-11.5%$176.90M$52.79M-19.93320AEMDAethlon Medical2.9672 of 5 stars$1.20-4.0%$56.00+4,566.7%-64.8%$3.11M$570K-0.0910News CoverageAnalyst RevisionABBVAbbVie4.9049 of 5 stars$185.80+1.9%$211.29+13.7%+13.3%$328.20B$56.33B79.0655,000Trending NewsAnalyst Revision Related Companies and Tools Related Companies Centene Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives UnitedHealth Group Alternatives Molina Healthcare Alternatives Select Medical Alternatives Joint Alternatives Aethlon Medical Alternatives AbbVie Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CI) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cigna Group Please log in to your account or sign up in order to add this asset to your watchlist. Share Cigna Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CI Stock Alerts